Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DW

Duncan Walker — 12 Patents

FTForma Therapeutics: 8 patents #34 of 86Top 40%
SLSmithkline Beecham Limited: 3 patents #419 of 1,624Top 30%
GWGlaxo Wellcome: 1 patents #211 of 449Top 50%
Summit, NJ: #90 of 570 inventorsTop 20%
New Jersey: #7,365 of 69,400 inventorsTop 15%
Overall (All Time): #396,045 of 4,157,543Top 10%
12 Patents All Time
Duncan Walker has been granted 12 US patents while listed as an inventor at Forma Therapeutics. The first was granted in 2002 and the most recent in April 2024. Duncan Walker ranks #396,045 of 4,157,543 US inventors in our database (top 9.5%). Patent records list Duncan Walker in Summit, NJ, US.

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11963956 Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) Patrick F. Kelly, Susan Ashwell, Blythe Thomson, Alan Collis, Jeff Davis +1 more 2024-04-23
11738018 Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) Susan Ashwell, Blythe Thomson, Patrick F. Kelly, Alan Collis, Jeff Davis +1 more 2023-08-29
11576906 Inhibiting mutant IDH-1 Patrick F. Kelly, Alan Collis, Jeff Davis, Susan Ashwell, Blythe Thomson +1 more 2023-02-14
11497743 Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation Patrick F. Kelly, Alan Collis, Jeff Davis, Susan Ashwell, Blythe Thomson +1 more 2022-11-15
11376246 Inhibiting mutant IDH-1 Patrick F. Kelly, Alan Collis, Jeff Davis, Susan Ashwell, Blythe Thomson +1 more 2022-07-05
11311527 Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) Patrick F. Kelly, Susan Ashwell, Blythe Thomson, Alan Collis, Jeff Davis +1 more 2022-04-26
11013733 Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1) Susan Ashwell, Blythe Thomson, Patrick F. Kelly, Alan Collis, Jeff Davis +1 more 2021-05-25
11013734 Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation Patrick F. Kelly, Alan Collis, Jeff Davis, Susan Ashwell, Blythe Thomson +1 more 2021-05-25
7105529 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects Stephen Thomas Davis, Scott Howard Dickerson, Stephen Frye, Philip Anthony Harris, Robert Neil Hunter, III +4 more 2006-09-12
6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors Stephen Thomas Davis, Scott Howard Dickerson, Stephen Frye, Philip Anthony Harris, Robert Neil Hunter, III +4 more 2003-04-01
6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors Stephen Thomas Davis, Scott Howard Dickerson, Philip Anthony Harris, Robert Neil Hunter, III, Lee Frederick Kuyper +2 more 2002-05-14 $79,502,000
6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors Stephen Thomas Davis, Scott Howard Dickerson, Philip Anthony Harris, Robert Neil Hunter, III, Lee Frederick Kuyper +3 more 2002-04-09